Whitehawk Therapeutics Inc. held its annual meeting of stockholders on June 11, 2025. During the meeting, the election of three Class II directors was approved. Additionally, the compensation of executive officers was approved on an advisory basis. The appointment of BDO USA, P.C. as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was also ratified.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Whitehawk Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-140810), on June 13, 2025, and is solely responsible for the information contained therein.